Skip to main content

Table 1 Serum acylcarnitine profile at diagnosis (TMS)

From: Late-onset multiple acyl-CoA dehydrogenase deficiency with breast cancer

 

Acylcarnitines

Values (μmol/L)

Cut-offsa (μmol/L)

Ratios

Values

Cut-offsa

1

C 2

10.42

25.0

C3/C0

 

0.20

2

C 3

0.66

6.00a

C3/C2

 

0.20

3

C 3DC

0.02

0.30a

C3/C16

 

3.50

4

C 4

0.39

1.30a

C4/C2

 

0.10

5

C 4-OH

0.01

0.65a

C4/C3

 

0.70

6

C 4DC

0.13

0.63

   

7

C 5

0.47

0.70a

C5/C2

 

0.05

8

C 5-OH

0.12

0.90a

C5-OH/C2

 

0.04

9

C 5:1

0.01

0.25a

C5:1/C2

 

0.20

10

C 5 DC

0.10

0.35a

C5DC/C2

 

0.02

11

C 6

0.75

0.45a

C5DC/C12

  

12

C6 OH

0.13

0.35

   

13

C 8

1.85

0.45a

C8/C2

0.18

0.03

14

C 10

3.69

0.45a

C10:1/C2

  

15

C 10:1

0.26

0.30a

   

16

C 10:2

0.02

0.15a

   

17

C 12

2.84

0.50

   

18

C 14

1.58

0.80a

C14/C2

0.15

0.03

19

C 14:1

0.96

0.60a

C14:1/C16

0.38

0.30

20

C14:2

0.15

0.15

   

21

C 16

2.24

7.50a

   

22

C 16-OH

0.02

0.15a

C16-OH/C2

 

0.01

23

C 18

1.02

2.50a

C18:1/C2

 

0.15

24

C 18-OH

0.01

0.10a

   

25

C 18: 1

1.58

3.50a

C18-OH/C2

 

0.10

26

C 18: 1-OH

0.02

0.16

C18:1OH/C2

 

0.01

 

Total

29.45

    
  1. Elevated C6, C8, C10, C10:1, C 12, C14, C14:1, suggestive of multiple acyl-CoA dehydrogenase deficiency (GA type II)
  2. aCDC cut-offs, 2013